Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
May 27, 2023 at 12:38 pm IST
Share
Caplin Point Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 3,892.8 million compared to INR 3,392.4 million a year ago. Revenue was INR 4,006.8 million compared to INR 3,507.5 million a year ago. Net income was INR 1,021.1 million compared to INR 790.6 million a year ago. Basic earnings per share from continuing operations was INR 13.45 compared to INR 10.43 a year ago. Diluted earnings per share from continuing operations was INR 13.33 compared to INR 10.33 a year ago.
For the full year, sales was INR 14,667.3 million compared to INR 12,694.1 million a year ago. Revenue was INR 15,227.1 million compared to INR 13,081.6 million a year ago. Net income was INR 3,762.6 million compared to INR 2,998.4 million a year ago. Basic earnings per share from continuing operations was INR 49.62 compared to INR 39.61 a year ago. Diluted earnings per share from continuing operations was INR 49.18 compared to INR 39.26 a year ago.
Caplin Point Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing, and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals and sachets (liquids and powders). It also manufactures a range of ointments, creams, gels and lotions. Its principal research and development facilities are in Tamil Nadu, India. Its principal manufacturing facility is in Puducherry, India. It has presence in Latin America (LATAM), Southern Africa and Francophone Africa along with a presence in United States of America and European region. The Companyâs subsidiaries include Caplin Point Far East Limited and Caplin Steriles Limited.
CAPLIN POINT LABORATORIES LIMITED 
